The molecular pathogenesis of spongiform encephalopathies;Molekulare Pathogenese der Spongiformen Enzephalopathien

Schweizer Archiv fur Neurologie und Psychiatrie

Volumn 147, Issue 4, 1996, Pages 133-140

  Aguzzi, Adriano ^a   Brandner, Sebastian ^a   Klein, Michael ^a   Blättler, Thomas ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BOVIDS; BRAIN SPONGIOSIS; DISEASE TRANSMISSION; HUMAN; INFECTION; MOLECULAR MODEL; NONHUMAN; PATHOGENESIS; REVIEW;

EID: 0029849934     PISSN: 02587661     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Cuille J, Chelle PL. Experimental transmission of trembling to the goat. C R Seances Acad Sci 1939; 208: 1058-1160.
2. Prusiner SB. Novel proteinaceous infectious particles cause serapie. Science 1982; 216: 136-144.
3. Hadlow WJ. Scrapie and kuru. Lancet 1959; 2: 289-290.
4. Hadlow WJ. Neuropathology and the scrapie-kuru connection. Brain Pathol 1995; 5: 27-31.
5. Beck E, Daniel PM, Alpers M, Gajdusek DC, Gibbs CJ. Experimental «kuru» in chimpanzees. A pathological report. Lancet 1966; 2: 1056-1059.
6. Gajdusek DC, Gibbs CJ, Alpers M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 1966; 209: 794-796.
7. Gibbs CJ, Jr., Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WB. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968; 161: 388-389.
8. Masters CL, Gajdusek DC, Gibbs CJ. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981; 104: 559-588.
9. Collinge J, Palmer MS, Sidle KCL, Gowland I, Medori R, Ironside JW, Lantos PL. Transmission of fatal familial insomnia to laboratory animals. Lancet 1995; 346: 569-570.
10. Tateishi J, Brown P, Kitamoto T, Hoque MZ, Roos R, Wollman R, Cervenakova L, Gajdusek DC. First experimental transmission of fatal familiar insomnia. Nature 1995; 376: 434-435.
11. Petersen RB, Tabaton M, Chen SG, Monari L, Richardson SL, Lynches T, Manetto V, Lanska DJ, Markesbery WR, Currier RD, et al. Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17. Neurology 1995; 45: 1062-1067.
12. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987; 121: 419-420.
13. Wilesmith JW, Hoinville LJ, Ryan JB, Sayers AR. Bovine spongiform encephalopathy: aspects of the clinical picture and analyses of possible changes 1986-1990. Vet Rec 1992; 130: 197-201.
14. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP. Further purification and characterization of scrapie prions. Biochemistry 1982; 21: 6942-6950.
15. Basler K, Oesch B, Scott M, Westaway D, Walchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46: 417-428.
16. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40: 735-746.
17. Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51: 229-240.
18. Baldwin MA, Stahl N, Reinders LG, Gibson BW, Prusiner SB, Burlingame AL. Permethylation and tandem mass spectrometry of oligosaccharides having free hexosamine: analysis of the glycoinositol phospholipid anchor glycan from the scrapie prion protein. Anal Biochem 1990; 191: 174-182.
19. Brown HR, Goller NL, Rudelli RD, Merz GS, Wolfe GC, Wisniewski HM, Robakis NK. The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells. Acta Neuropathol Berl 1990; 80: 1-6.
20. Moser M, Colello RJ, Pott U, Oesch B. Developmental expression of the prion protein gene in glial cells. Neuron 1995; 14: 509-517.
21. Kitamoto T, Muramoto T, Mohri S, Doh ura K, Tateishi J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J Virol 1991; 65: 6292-6295.
22. Muramoto T, Kitamoto T, Hoque MZ, Tateishi J, Goto I. Species barrier prevents an abnormal isoform of prion protein from accumulating in follicular dendritic cells of mice with Creutzfeldt-Jakob disease. J Virol 1993; 67: 6808-6810.
23. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994; 370(6489): 471-474.
24. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury PT, Jr., Caughey B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci U S A 1995; 92: 3923-3927.
25. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein [see comments]. Nature 1995; 375: 698-700.
26. Taraboulos A, Serban D, Prusiner SB. Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells J Cell Biol 1990; 110: 2117-2132.
27. McKinley MP, Taraboulos A, Kenaga L, Serban D, Stieber A, DeArmond SJ, Prusiner SB, Gonatas N. Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest 1991; 65: 622-630.
28. Gasset M, Baldwin MA, Fletterick RJ, Prusiner SB. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Nad Acad Sci U S A 1993; 90: 1-5.
29. Zhang H, Kaneko K, Nguyen JT, Livshits TL, Baldwin MA, Cohen FE, James TL, Prusiner SB. Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J Mol Biol 1995; 250: 514-526.
30. Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J Gen Virol 1992; 73: 1025-1029.
31. Meyer N, Rosenbaum V, Schmidt B, Gilles K, Mirenda C, Groth D, Prusiner SB, Riesner D. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol 1991; 72: 37-49.
32. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, Prusiner SB. Distinct prion proteins in short and long scrapie incubation period mice. Cell 1987; 51: 651-662.
33. Carlson GA, Westaway D, Goodman PA, Peterson M, Marshall ST, Prusiner SB. Genetic control of prion incubation period in mice. Ciba Found Symp 1988; 135: 84-99.
34. Lowenstein DH, Butler DA, Westaway D, McKinley MP, DeArmond SJ, Prusiner SB. Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins. Mol Cell Biol 1990; 10: 1153-1163.
35. Hunter N, Foster JD, Dickinson AG, Hope J. Linkage of the gene for the scrapie-associated fibril protein (PrP) to the Sip gene in Cheviot sheep. Vet Rec 1989; 124: 364-366.
36. Westaway D, Mirenda CA, Foster D, Zebarjadian Y, Scott M, Torchia M, Yang SL, Serban H, DeArmond SJ, Ebeling C, et al. Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice. Neuron 1991; 7: 59-68.
37. Büeler HR, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356: 577-582.
38. Büeler HR, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73: 1339-1347.
39. Weissmann C, Büeler H, Sailer A, Fischer M, Aguet M, Aguzzi A. Role of PrP in prion diseases. Br Med Bull 1993; 49: 995-1011.
40. Sailer A, Büeler H, Fischer M, Aguzzi A, Weissmann C. No propagation of prions in mice devoid of PrP. Cell 1994; 77: 967-968.
41. Büeler H, Raeber A, Sailer A, Fischer M, Aguzzi A, Weissmann C. High prion and PrPsc levels but delayed onset of disease in scrapie inoculated mice heterozygous for a disrupted PrP gene. Molecular Medicine 1994; 1(1): 19-30.
42. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83: 79-90.
43. Prusiner SB. The prion diseases. Sci Am 1995; 272: 48-51, 54.
44. Collinge J, Palmer MS, Sidle KCL, Hill AF, Gowland I, Meads J, Asante E, Bradley R, Doey LJ, Lantos PL. Unaltered susceptibility to BSE in transgenic mcie expressing human prion protein. Nature 1995; 378: 779-783.
45. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 1989; 338: 342-345.
46. Collinge J, Harding AE, Owen F, Poulter M, Lofthouse R, Boughey AM, Shah T, Crow TJ. Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis. Lancet 1989; 2: 15-17.
47. Doh ura K, Tateishi J, Sasaki H, Kitamoto T, Sakaki Y. Pro leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 1989; 163: 974-979.
48. Owen F, Poulter M, Collinge J, Leach M, Lofthouse R, Crow TJ, Harding AE. A dementing illness associated with a novel insertion in the prion protein gene. Brain Res Mol Brain Res 1992; 13: 155-157.
49. Goldfarb LG, Brown P, McCombie WR, Goldgaber D, Swergold GD, Wills PR, Cervenakova L, Baron H, Gibbs CJ, Jr., Gajdusek DC. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A 1991; 88: 10926-10930.
50. Kitamoto T, Iizuka R, Tateishi J. An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 1993; 792: 525-531.
51. Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992; 326: 444-449.
52. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986; 315: 997-1003.
53. Perani D, Cortelli P, Lucignani G, Montagna P, Tinuper P, Gallassi R, Gambetti P, Lenzi GL, Lugaresi E, Fazio F. 18F-FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology 1993; 43: 2565-2569.
54. Manetto V, Medori R, Cortelli P, Montagna P, Tinuper P, Baruzzi A, Rancurel G, Hauw JJ, Vanderhaeghen JJ, Mailleux P, et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 1992; 42: 312-319.
55. Petersen RB, Tabaton M, Berg L, Schrank B, Torack RM, Leal S, Julien J, Vital C, Deleplanque B, Pendlebury WW, et al. Analysis of the prion protein gene in thalamic dementia. Neurology 1992; 42: 1859-1863.
56. Medori R, Montagna P, Tritschler HJ, LeBlanc A, Cortelli P, Tinuper P, Lugaresi E, Gambetti P. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 1992; 42: 669-670.
57. Brown P, Goldfarb LG, Kovanen J, Haltia M, Cathala F, Sulima M, Gibbs CJ, Jr., Gajdusek DC. Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol 1992; 31: 282-285.
58. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258: 806-808.
59. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-342.
60. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-1442.
61. Gambetti P, Petersen R, Monari L, Tabaton M, Autilio Gambetti L, Cortelli P, Montagna P, Lugaresi E. Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 1993; 49: 980-994.
62. Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990; 250: 1587-1590.
63. Isenmann S, Brandner S, Sure U, Aguzzi A. Telencephalic transplants in mice: characterization of growth and differentiation patterns. [In Press] Neuropathol Appl Neurobiol 1996;
64. Isenmann S, Molthagen M, Brandner S, Kühne G, Bartsch U, Magyar JP, Sure U, Schachner M, Aguzzi A. Neural transplants of AMOG/b2-deficient mice survive but do not express the b2-subunit of the Na,K-ATPase. Glia 1995; 15: 377-388.
65. Isenmann S, Brandner S, Kühne G, Boner J, Aguzzi A. Comparative in vivo and pathological analysis of the blood-brain barrier in mouse telencephalic transplants. [In Press] Neuropathol Appl Neurobiol 1996.
66. Brandner S, Isenmann S, Raeber A, et al. Normal host prion protein required for scrapie neurotoxicity. Nature 1996; 379: 339-343.
67. Jeffrey M, Goodsir CM, Bruce M, McBride PA, Scott JR, Halliday WG. Correlative light and electron microscopy studies of PrP localisation in 87V scrapie. Brain Res 1994; 656: 329-343.
68. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 1993; 362: 543-546.
69. Müller WE, Ushijima H, Schroder HC, Forrest JM, Schatton WF, Rytik PG, Heffner Lauc M. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 1993; 246: 261-267.
70. Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL. Prion dementia without characteristic pathology. Lancet 1990; 336: 7-9.
71. Hayward PA, Bell JE, Ironside JW. Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1994; 20: 375-383.
72. Shyng SL, Huber MT, Harris DA. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 1993; 268: 15922-15928.
73. Manson JC, Clarke AR, McBride PA, McConnell I, Hope J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 1994; 3: 331-340.